Ingredient record · Blood pressure medicine (ARB)

Losartan: bans, restrictions and failed batches in India

Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026

1 entry containing Losartan is on India's banned-drugs list, and 1 is banned today. 9 batches of medicines containing Losartan failed a government lab test between February 2022 and October 2025, from 7 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.

1
Banned combinations in force
0
Other listed orders (stayed, restricted, quashed)
9
Batches failed a lab test
Oct 2025
Latest lab alert

On the banned-drugs list

Losartan on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.

Drug / combinationActionNotificationDateOrderStatus note
Hydrochlorothiazide + Ramipril + Losartan PotassiumFixed-dose combination · cardiac Banned S.O. 259(E) 11 January 2019 Other orders One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021.

Products that failed lab tests

Product names as printed by the testing labs, grouped. Open a product to see every batch number.

ProductBatchesMakersLatest
Losartan32Jan 2025
Losartan Potassium33Jan 2025
Losartan Potassium Amlodipine11Oct 2025
Losartan Potassium Hydrochlorthiazide11Apr 2025
Losacon H11Sep 2022

Most recent failed batches

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Losartan Potassium & Amlodipine Tablets IP TL-1470007Mfg 2023-12 · Exp 2026-11 Centurion Remedies Pvt. LtdGujarat The sample does not conform to the IP with respect to Assay and Dissolution.Assay DTL, JaipurState lab Oct 2025
Losartan Potassium 50mg & Hydrochlorthiazide 12.5mg Tablets LMT251666Mfg 2025-02 · Exp 2027-01 Life Max Cancer LaboratoriesUttarakhand Dissolution Test: The Dissolution of Losartan Potassium and Hydrochlorthiazide does not complies within the Prescribed limit of not less than Q value i.e. 70% of labelled claim as stated in I.P 2022.Dissolution State Drugs Laboratory, PunjabState lab Apr 2025
Losartan Tablets IP 50 mg LMT240826Mfg 2024-07 · Exp 2026-06 Life Max Cancer Laboratories DissolutionDissolution RDTL GuwahatiCDSCO lab Jan 2025
Losartan Potassium Tab IP 25 mg D 2615/24- 25Mfg ? · Exp ? Kerala Medical Services Corporation LtdKerala It fails the ?Descriptive Part? for the tablets as per IP , tablets should have sufficient hardness for handling without crumbling and breakingOther DTL ThiruvananthapuramState lab Jan 2025
Losartan Potassium Tablets IP 50 mg HLOA09Mfg 2023-11 · Exp 2025-10 Hindusthan Antibiotics LtdHaryana It fails the test ?Dissolution? as per IP as specified in the Laboratory ProtocolDissolution DTL ThiruvananthapuramState lab Dec 2024
Losartan Potassium Tablets IP 50 mg HLOA06Mfg 2023-11 · Exp 2025-10 Hindustan Antibiotics LtdHaryana It fails the test ?Dissolution? as per IPDissolution DTL ThiruvananthapuramState lab Jun 2024
Losartan Tablets I.P. 25 mg 3803821Mfg 2021-11 · Exp 2024-10 Karnataka Antibiotics & Pharmaceuticals LtdKarnataka DissolutionDissolution CDL KolkataCDSCO lab Apr 2023
Losacon-H (Losartan Potassium & Hydrochlorothiazide Tablets I.P.) C21L262001Mfg 2022-02 · Exp 2024-01 Concept Pharmaceuticals LtdMaharashtra Assay of HydrochlorthiazideAssay CDL KolkataCDSCO lab Sep 2022
Losartan Tablets I.P. 25 mg 3800221Mfg 2021-02 · Exp 2024-01 Karnataka Antibiotics & Pharmaceuticals LtdKarnataka DissolutionDissolution CDL KolkataCDSCO lab Feb 2022

Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.